Enfusion Inc - Class A

2
NYSE:ENFN (USA)   Class A
$ 9.67 +0.03 (+0.31%) 08:08 PM EST
321.33
P/B:
14.92
Market Cap:
$ 888.78M
Enterprise V:
$ 868.59M
Volume:
301.29K
Avg Vol (2M):
346.04K
Volume:
301.29K
Avg Vol (2M):
346.04K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for ENFN ( Enfusion Inc ) from 2021 to May 17 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Enfusion stock (ENFN) PE ratio as of May 17 2024 is 321.33. More Details

Enfusion Inc (ENFN) PE Ratio (TTM) Chart

To

Enfusion Inc (ENFN) PE Ratio (TTM) Historical Data

Total 648
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8
Enfusion PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-18 322.3 2024-03-15 116.3
2024-05-17 322.3 2024-03-14 115.8
2024-05-16 321.3 2024-03-13 116.5
2024-05-15 314.3 2024-03-12 117.0
2024-05-14 308.7 2024-03-11 106.5
2024-05-13 305.0 2024-03-08 103.8
2024-05-10 301.7 2024-03-07 104.1
2024-05-09 308.7 2024-03-06 102.1
2024-05-08 325.7 2024-03-05 104.4
2024-05-07 324.3 2024-03-04 107.5
2024-05-06 326.0 2024-03-01 108.4
2024-05-03 319.0 2024-02-29 108.4
2024-05-02 317.3 2024-02-28 109.1
2024-05-01 317.0 2024-02-27 116.6
2024-04-30 310.3 2024-02-26 118.1
2024-04-29 316.7 2024-02-23 119.6
2024-04-26 314.0 2024-02-22 116.9
2024-04-25 314.0 2024-02-21 115.0
2024-04-24 310.0 2024-02-20 116.1
2024-04-23 311.7 2024-02-16 113.5
2024-04-22 307.7 2024-02-15 111.8
2024-04-19 308.0 2024-02-14 111.6
2024-04-18 303.7 2024-02-13 106.3
2024-04-17 310.0 2024-02-12 106.3
2024-04-16 309.0 2024-02-09 104.4
2024-04-15 305.3 2024-02-08 101.6
2024-04-12 319.0 2024-02-07 99.1
2024-04-11 317.7 2024-02-06 98.9
2024-04-10 318.7 2024-02-05 97.9
2024-04-09 322.0 2024-02-02 98.1
2024-04-08 320.0 2024-02-01 97.3
2024-04-05 313.3 2024-01-31 98.8
2024-04-04 306.7 2024-01-30 100.4
2024-04-03 310.7 2024-01-29 106.3
2024-04-02 306.7 2024-01-26 105.4
2024-04-01 308.0 2024-01-25 106.9
2024-03-28 308.3 2024-01-24 108.5
2024-03-27 115.4 2024-01-23 112.1
2024-03-26 113.8 2024-01-22 112.5
2024-03-25 114.4 2024-01-19 110.3
2024-03-22 115.4 2024-01-18 109.8
2024-03-21 116.0 2024-01-17 109.0
2024-03-20 114.9 2024-01-16 110.1
2024-03-19 114.8 2024-01-12 109.8
2024-03-18 113.6 2024-01-11 108.9

Enfusion Inc (ENFN) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Enfusion Inc
NAICS : 541511 SIC : 7372
ISIN : US2928121043

Share Class Description:

ENFN: Class A
Description
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.